Life Technologies Corp.

Controls & Controllers

Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers

CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced that the new Center for Personalized Medicine (CPM) at Roswell Park Cancer Institute (RPCI) has purchased four Ion Proton™ sequencers and two Ion Personal Genome Machine™ (PGM™) sequencers. Founded in 1898, Roswell Park Cancer Institute was one of the first cancer centers in the country to be named a National...

Read More »
Controls & Controllers

Life Technologies Bolsters Its 60 Percent Market Share Lead in Benchtop Sequencers with 12 New Ion Torrent(TM) Products

More than 90 peer-reviewed papers and the world's largest online sequencing community reflects broad adoption of Ion Torrent™ technology CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced a dozen innovative new products for the Ion Torrent platform that will make sequencing faster, simpler and more accessible for scientists, driving discovery and advancing clinical...

Read More »
Controls & Controllers

Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers

CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced that the new Center for Personalized Medicine (CPM) at Roswell Park Cancer Institute (RPCI) has purchased four Ion Proton™ sequencers and two Ion Personal Genome Machine™ (PGM™) sequencers. Founded in 1898, Roswell Park Cancer Institute was one of the first cancer centers in the country to be named a National...

Read More »
Controls & Controllers

Life Technologies Bolsters Its 60 Percent Market Share Lead in Benchtop Sequencers with 12 New Ion Torrent(TM) Products

More than 90 peer-reviewed papers and the world's largest online sequencing community reflects broad adoption of Ion Torrent™ technology CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced a dozen innovative new products for the Ion Torrent platform that will make sequencing faster, simpler and more accessible for scientists, driving discovery and advancing clinical...

Read More »

All Topics